Once-weekly semaglutide in adults with overweight or obesity
doi: 10.1016/j.it.2017.04.006 66 GibbsC
Eli Lilly has indicated plans to pursue additional legal action and has sent cease-and-desist letters to approximately fifty other compounders and telehealth companies
Optimized Protocol for Selective Fat Metabolism Dosing: Starting dose: 250 mcg per day (subcutaneous injection) Standard dose: 300-500 mcg per day after 1-2 weeks Frequency: Once daily or divided into two doses (morning and early afternoon) Administration: Route: Subcutaneous injection (abdomen, thigh, or upper arm) Timing: Morning fasted state ideal, or 30-60 minutes before cardio Storage: Reconstituted peptide refrigerated, typically stable 30-60 days Cycle Length: 12-16 weeks for initial assessment, with potential for extended protocols based on clinical trial data showing safe use up to 24 weeks
It triggers support cells to feed healing neurons
To put the truth into perspective, its been comprehensively looked at in a David McAuley article in Global RPh, which is aimed at helping physicians, clinical researchers, and healthcare professionals understand the risks of this stack